BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 35491430)

  • 1. Comparing the levels of CTLA-4-dependent biological defects in patients with LRBA deficiency and CTLA-4 insufficiency.
    Catak MC; Akcam B; Bilgic Eltan S; Babayeva R; Karakus IS; Akgun G; Baser D; Bulutoglu A; Bayram F; Kasap N; Kiykim A; Hancioglu G; Kokcu Karadag SI; Kendir Demirkol Y; Ozen S; Cekic S; Ozcan D; Edeer Karaca N; Sasihuseyinoglu AS; Cansever M; Ozek Yucel E; Tamay Z; Altintas DU; Aydogmus C; Celmeli F; Cokugras H; Gulez N; Genel F; Metin A; Guner SN; Kutukculer N; Keles S; Reisli I; Kilic SS; Yildiran A; Karakoc-Aydiner E; Lo B; Ozen A; Baris S
    Allergy; 2022 Oct; 77(10):3108-3123. PubMed ID: 35491430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exaggerated follicular helper T-cell responses in patients with LRBA deficiency caused by failure of CTLA4-mediated regulation.
    Alroqi FJ; Charbonnier LM; Baris S; Kiykim A; Chou J; Platt CD; Algassim A; Keles S; Al Saud BK; Alkuraya FS; Jordan M; Geha RS; Chatila TA
    J Allergy Clin Immunol; 2018 Mar; 141(3):1050-1059.e10. PubMed ID: 28601686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Murine LRBA deficiency causes CTLA-4 deficiency in Tregs without progression to immune dysregulation.
    Burnett DL; Parish IA; Masle-Farquhar E; Brink R; Goodnow CC
    Immunol Cell Biol; 2017 Oct; 95(9):775-788. PubMed ID: 28611475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic modalities and clinical outcomes in a large cohort with LRBA deficiency and CTLA4 insufficiency.
    Taghizade N; Babayeva R; Kara A; Karakus IS; Catak MC; Bulutoglu A; Haskologlu ZS; Akay Haci I; Tunakan Dalgic C; Karabiber E; Bilgic Eltan S; Yorgun Altunbas M; Sefer AP; Sezer A; Kokcu Karadag SI; Arik E; Karali Z; Ozhan Kont A; Tuzer C; Karaman S; Mersin SS; Kasap N; Celik E; Kocacik Uygun DF; Aydemir S; Kiykim A; Aydogmus C; Ozek Yucel E; Celmeli F; Karatay E; Bozkurtlar E; Demir S; Metin A; Karaca NE; Kutukculer N; Aksu G; Guner SN; Keles S; Reisli I; Kendir Demirkol Y; Arikoglu T; Gulez N; Genel F; Kilic SS; Aytekin C; Keskin O; Yildiran A; Ozcan D; Altintas DU; Ardeniz FO; Dogu EF; Ikinciogullari KA; Karakoc-Aydiner E; Ozen A; Baris S
    J Allergy Clin Immunol; 2023 Dec; 152(6):1634-1645. PubMed ID: 37595759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Phenotypes and Immunological Characteristics of 18 Egyptian LRBA Deficiency Patients.
    Meshaal S; El Hawary R; Adel R; Abd Elaziz D; Erfan A; Lotfy S; Hafez M; Hassan M; Johnson M; Rojas-Restrepo J; Gamez-Diaz L; Grimbacher B; Shoman W; Abdelmeguid Y; Boutros J; Galal N; El-Guindy N; Elmarsafy A
    J Clin Immunol; 2020 Aug; 40(6):820-832. PubMed ID: 32506362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AUTOIMMUNE DISEASE. Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy.
    Lo B; Zhang K; Lu W; Zheng L; Zhang Q; Kanellopoulou C; Zhang Y; Liu Z; Fritz JM; Marsh R; Husami A; Kissell D; Nortman S; Chaturvedi V; Haines H; Young LR; Mo J; Filipovich AH; Bleesing JJ; Mustillo P; Stephens M; Rueda CM; Chougnet CA; Hoebe K; McElwee J; Hughes JD; Karakoc-Aydiner E; Matthews HF; Price S; Su HC; Rao VK; Lenardo MJ; Jordan MB
    Science; 2015 Jul; 349(6246):436-40. PubMed ID: 26206937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abatacept as a Long-Term Targeted Therapy for LRBA Deficiency.
    Kiykim A; Ogulur I; Dursun E; Charbonnier LM; Nain E; Cekic S; Dogruel D; Karaca NE; Cogurlu MT; Bilir OA; Cansever M; Kapakli H; Baser D; Kasap N; Kutlug S; Altintas DU; Al-Shaibi A; Agrebi N; Kara M; Guven A; Somer A; Aydogmus C; Ayaz NA; Metin A; Aydogan M; Uncuoglu A; Patiroglu T; Yildiran A; Guner SN; Keles S; Reisli I; Aksu G; Kutukculer N; Kilic SS; Yilmaz M; Karakoc-Aydiner E; Lo B; Ozen A; Chatila TA; Baris S
    J Allergy Clin Immunol Pract; 2019; 7(8):2790-2800.e15. PubMed ID: 31238161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different Apples, Same Tree: Visualizing Current Biological and Clinical Insights into CTLA-4 Insufficiency and LRBA and DEF6 Deficiencies.
    Gámez-Díaz L; Seidel MG
    Front Pediatr; 2021; 9():662645. PubMed ID: 33996698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune checkpoint deficiencies and autoimmune lymphoproliferative syndromes.
    Gámez-Díaz L; Grimbacher B
    Biomed J; 2021 Aug; 44(4):400-411. PubMed ID: 34384744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological phenotype of the murine Lrba knockout.
    Gámez-Díaz L; Neumann J; Jäger F; Proietti M; Felber F; Soulas-Sprauel P; Perruzza L; Grassi F; Kögl T; Aichele P; Kilimann M; Grimbacher B; Jung S
    Immunol Cell Biol; 2017 Oct; 95(9):789-802. PubMed ID: 28652580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The imbalance of circulating T helper subsets and regulatory T cells in patients with LRBA deficiency: Correlation with disease severity.
    Azizi G; Mirshafiey A; Abolhassani H; Yazdani R; Ghanavatinejad A; Noorbakhsh F; Rezaei N; Aghamohammadi A
    J Cell Physiol; 2018 Nov; 233(11):8767-8777. PubMed ID: 29806698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary manifestations of immune dysregulation in CTLA-4 haploinsufficiency and LRBA deficiency.
    Krone KA; Winant AJ; Vargas SO; Platt CD; Bartnikas LM; Janssen E; Lillehei C; Lee EY; Fishman MP; Casey A
    Pediatr Pulmonol; 2021 Jul; 56(7):2232-2241. PubMed ID: 33710794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Spectrum of Clinical Findings from ALPS to CVID: Several Novel LRBA Defects.
    Cagdas D; Halaçlı SO; Tan Ç; Lo B; Çetinkaya PG; Esenboğa S; Karaatmaca B; Matthews H; Balcı-Hayta B; Arıkoğlu T; Ezgü F; Aladağ E; Saltık-Temizel İN; Demir H; Kuşkonmaz B; Okur V; Gümrük F; Göker H; Çetinkaya D; Boztuğ K; Lenardo M; Sanal Ö; Tezcan İ
    J Clin Immunol; 2019 Oct; 39(7):726-738. PubMed ID: 31432443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multifocal gastric adenocarcinoma in a patient with LRBA deficiency.
    Bratanič N; Kovač J; Pohar K; Trebušak Podkrajšek K; Ihan A; Battelino T; Avbelj Stefanija M
    Orphanet J Rare Dis; 2017 Jul; 12(1):131. PubMed ID: 28720148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulatory T-cell deficiency and immune dysregulation, polyendocrinopathy, enteropathy, X-linked-like disorder caused by loss-of-function mutations in LRBA.
    Charbonnier LM; Janssen E; Chou J; Ohsumi TK; Keles S; Hsu JT; Massaad MJ; Garcia-Lloret M; Hanna-Wakim R; Dbaibo G; Alangari AA; Alsultan A; Al-Zahrani D; Geha RS; Chatila TA
    J Allergy Clin Immunol; 2015 Jan; 135(1):217-27. PubMed ID: 25468195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ABACHAI clinical trial protocol: Safety and efficacy of abatacept (s.c.) in patients with CTLA-4 insufficiency or LRBA deficiency: A non controlled phase 2 clinical trial.
    Krausz M; Uhlmann A; Rump IC; Ihorst G; Goldacker S; Sogkas G; Posadas-Cantera S; Schmidt R; Feißt M; Alsina L; Dybedal I; Recher M; Warnatz K; Grimbacher B
    Contemp Clin Trials Commun; 2022 Dec; 30():101008. PubMed ID: 36262801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Expression of LRBA and CTLA-4 Proteins in Common Variable Immunodeficiency Patients.
    Salami F; Fekrvand S; Yazdani R; Shahkarami S; Azizi G; Bagheri Y; Delavari S; Shariati S; Mahdaviani SA; Nabavi M; Shirkani A; Abolhassani H; Samadi M; Aghamohammadi A
    Immunol Invest; 2022 Feb; 51(2):381-394. PubMed ID: 33191838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive comparison between 222 CTLA-4 haploinsufficiency and 212 LRBA deficiency patients: a systematic review.
    Jamee M; Hosseinzadeh S; Sharifinejad N; Zaki-Dizaji M; Matloubi M; Hasani M; Baris S; Alsabbagh M; Lo B; Azizi G
    Clin Exp Immunol; 2021 Jul; 205(1):28-43. PubMed ID: 33788257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unusual Late-onset Enteropathy in a Patient With Lipopolysaccharide-responsive Beige-like Anchor Protein Deficiency.
    Maggiore R; Grossi A; Fioredda F; Palmisani E; Terranova P; Cappelli E; Lanza T; Pierri F; Guardo D; Calvillo M; Micalizzi C; Beccaria A; Coccia MC; Arrigo S; Dufour C; Ceccherini I; Miano M
    J Pediatr Hematol Oncol; 2020 Nov; 42(8):e768-e771. PubMed ID: 31876783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying functional defects in patients with immune dysregulation due to LRBA and CTLA-4 mutations.
    Hou TZ; Verma N; Wanders J; Kennedy A; Soskic B; Janman D; Halliday N; Rowshanravan B; Worth A; Qasim W; Baxendale H; Stauss H; Seneviratne S; Neth O; Olbrich P; Hambleton S; Arkwright PD; Burns SO; Walker LS; Sansom DM
    Blood; 2017 Mar; 129(11):1458-1468. PubMed ID: 28159733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.